These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27546479)

  • 41. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
    Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
    J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice.
    Vigário AM; Belnoue E; Grüner AC; Mauduit M; Kayibanda M; Deschemin JC; Marussig M; Snounou G; Mazier D; Gresser I; Rénia L
    J Immunol; 2007 May; 178(10):6416-25. PubMed ID: 17475871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
    Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
    Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenic CD8+ T cells in experimental cerebral malaria.
    Howland SW; Claser C; Poh CM; Gun SY; Rénia L
    Semin Immunopathol; 2015 May; 37(3):221-31. PubMed ID: 25772948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood-cerebrospinal fluid barrier: another site disrupted during experimental cerebral malaria caused by Plasmodium berghei ANKA.
    Ngo-Thanh H; Sasaki T; Suzue K; Yokoo H; Isoda K; Kamitani W; Shimokawa C; Hisaeda H; Imai T
    Int J Parasitol; 2020 Dec; 50(14):1167-1175. PubMed ID: 32882285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxic T Lymphocyte Granzyme-b mediates neuronal cell death during Plasmodium berghei ANKA induced experimental cerebral malaria.
    Eeka P; Phanithi PB
    Neurosci Lett; 2018 Jan; 664():58-65. PubMed ID: 29129674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria.
    DellaValle B; Hempel C; Staalsoe T; Johansen FF; Kurtzhals JA
    Malar J; 2016 Aug; 15(1):427. PubMed ID: 27554094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.
    Pamplona A; Ferreira A; Balla J; Jeney V; Balla G; Epiphanio S; Chora A; Rodrigues CD; Gregoire IP; Cunha-Rodrigues M; Portugal S; Soares MP; Mota MM
    Nat Med; 2007 Jun; 13(6):703-10. PubMed ID: 17496899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral administration of IPI549 protects mice from neuropathology and an overwhelming inflammatory response during experimental cerebral malaria.
    Jin Z; Pang W; Zhao Y; Min H; Yao S; Bian Z; Wen Y; Peng C; Cao Y; Zheng L
    Int J Parasitol Drugs Drug Resist; 2024 Aug; 25():100539. PubMed ID: 38621317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of memory CD8+ T cells and their recall responses during blood-stage infection with Plasmodium berghei ANKA.
    Miyakoda M; Kimura D; Honma K; Kimura K; Yuda M; Yui K
    J Immunol; 2012 Nov; 189(9):4396-404. PubMed ID: 23008449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heme dampens T-cell sequestration by modulating glial cell responses during rodent cerebral malaria.
    Dalko E; Genete D; Auger F; Dovergne C; Lambert C; Herbert F; Cazenave PA; Roland J; Pied S
    Brain Behav Immun; 2016 Nov; 58():280-290. PubMed ID: 27477919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation.
    Pais TF; Chatterjee S
    J Neuroimmunol; 2005 Jun; 163(1-2):73-83. PubMed ID: 15885309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
    Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
    PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8
    Wang J; Li Y; Shen Y; Liang J; Li Y; Huang Y; Liu X; Jiang D; Yang S; Zhao Y; Yang K
    Front Immunol; 2018; 9():3157. PubMed ID: 30693001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein kinase C-theta is required for development of experimental cerebral malaria.
    Fauconnier M; Bourigault ML; Meme S; Szeremeta F; Palomo J; Danneels A; Charron S; Fick L; Jacobs M; Beloeil JC; Ryffel B; Quesniaux VF
    Am J Pathol; 2011 Jan; 178(1):212-21. PubMed ID: 21224058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating proteasome inhibitors as potential adjunct therapies for experimental cerebral malaria.
    Howland SW; Ng GX; Chia SK; Rénia L
    Parasite Immunol; 2015 Nov; 37(11):599-604. PubMed ID: 26366636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition.
    Clark CJ; Mackay GM; Smythe GA; Bustamante S; Stone TW; Phillips RS
    Infect Immun; 2005 Aug; 73(8):5249-51. PubMed ID: 16041050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Dietary Folate in Mice Alters Immune Response and Reduces Survival after Malarial Infection.
    Meadows DN; Bahous RH; Best AF; Rozen R
    PLoS One; 2015; 10(11):e0143738. PubMed ID: 26599510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.